Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nouri Neamati

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
Current Topics in Medicinal Chemistry|April 12, 2002
New paradigms in drug design and discoveryNouri Neamati, Joseph J Barchi
Theranostics|May 7, 2011
Integrin targeted therapeuticsMelissa Millard, Srinivas Odde, Nouri Neamati
RSC Advances|May 11, 2022
2,3-Dihydroquinazolin-4(1<i>H</i>)-one as a privileged scaffold in drug designMariateresa Badolato, Francesca Aiello, Nouri Neamati
Drug Discovery Today|November 5, 2013
Protein disulfide isomerase: a promising target for cancer therapyShili Xu, Saranya Sankar, Nouri Neamati
ACS Pharmacology & Translational Science|April 16, 2026
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging ApplicationsNikola Knoll, Nouri Neamati, Aykut Üren
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Inhibition of the strand transfer step of HIV-1 integrase by non-natural dinucleotidesGuochen Chi, Nouri Neamati, Vasu Nair
Bioorganic & Medicinal Chemistry|January 13, 2006
Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxidesZdziasław Brzozowski, Franciszek Saczewski, Nouri Neamati
Journal of Medicinal Chemistry|December 13, 2005
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integraseRaveendra Dayam, Tino Sanchez, Nouri Neamati
Trends in Pharmacological Sciences|September 25, 2007
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategyLaith Q Al-Mawsawi, Nouri Neamati
Journal of Medicinal Chemistry|January 28, 2021
Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91Maha Hanafi, Xinde Chen, Nouri Neamati
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
Current Topics in Medicinal Chemistry|April 12, 2002
New paradigms in drug design and discoveryNouri Neamati, Joseph J Barchi
Theranostics|May 7, 2011
Integrin targeted therapeuticsMelissa Millard, Srinivas Odde, Nouri Neamati
RSC Advances|May 11, 2022
2,3-Dihydroquinazolin-4(1<i>H</i>)-one as a privileged scaffold in drug designMariateresa Badolato, Francesca Aiello, Nouri Neamati
Drug Discovery Today|November 5, 2013
Protein disulfide isomerase: a promising target for cancer therapyShili Xu, Saranya Sankar, Nouri Neamati
ACS Pharmacology & Translational Science|April 16, 2026
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging ApplicationsNikola Knoll, Nouri Neamati, Aykut Üren
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Inhibition of the strand transfer step of HIV-1 integrase by non-natural dinucleotidesGuochen Chi, Nouri Neamati, Vasu Nair
Bioorganic & Medicinal Chemistry|January 13, 2006
Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxidesZdziasław Brzozowski, Franciszek Saczewski, Nouri Neamati
Journal of Medicinal Chemistry|December 13, 2005
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integraseRaveendra Dayam, Tino Sanchez, Nouri Neamati
Trends in Pharmacological Sciences|September 25, 2007
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategyLaith Q Al-Mawsawi, Nouri Neamati
Journal of Medicinal Chemistry|January 28, 2021
Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91Maha Hanafi, Xinde Chen, Nouri Neamati
Pageof 24